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Access to expert gynecologic oncology care is hampered by geographic (1), racial (2), and socio-
economic disparities (3). As cancer care grows in complexity and expense (4) with an aging and 
increasingly diverse population, the Institute of Medicine and others have called for improvements 
in cancer care delivery and research (5, 6). The growing workforce gap in supply of gynecologic 
oncologists – where demand is increasing, but number of providers remains stagnant (2) – highlights 
the need for fully utilizing the skills of all clinicians working across the cancer control continuum 
(prevention, screening, treatment, survivorship, and end of life). To that end, nurses can have an 
enormous impact on improving and expanding access to oncology care as clinicians, designers, and 
leaders of initiatives to improve care. Nurses comprise the largest group of health-care providers in 
the U.S. (7). In its 2010 report on the future of nursing, the Institute of Medicine called for all nurses 
to practice to the full extent of their nursing “education, training, and competencies” (5). We argue 
that promoting and expanding nurses’ roles within innovative, multidisciplinary models of care in 
women’s health is essential in order to improve growing gaps in cancer care.
pREVEnTiOn
primary prevention
Prevention of common women’s cancers includes promotion of healthy lifestyles and vaccination, 
though the potential for widespread dissemination is hampered by ineffective implementation. For 
example, the prophylactic human papillomavirus (HPV) vaccine is a groundbreaking prevention 
tool which is now available to prevent cervical cancer. Uptake of the vaccine among youth in the U.S. 
is inadequate despite widespread insurance coverage and availability. In 2014, <40% of U.S. teenagers 
completed the three dose series before 18 years of age (8). Although physician recommendation 
has been shown to improve uptake of HPV vaccines (9), the recommendations of nurses could be 
equally or more effective in increasing HPV vaccine uptake in primary care, especially in rural and 
underserved areas (10). Gallagher et al.’s systematic review demonstrated that, despite challenges, 
school-based HPV vaccination programs in the U.S. and other countries have achieved higher levels 
of vaccine uptake when compared with those conducted at health-care facilities (11). School nurses 
are integral to such programs, where qualitative research by Boyce and Holmes demonstrated that 
they have the potential to promote vaccination of medically underserved children (12). In particular, 
school nurses often serve as opinion leaders in middle schools – where the target population for HPV 
vaccination is found – and can intervene with targeted education, follow-up, and tool kits to promote 
vaccination among students and parents (13, 14).
Health Education
Advanced practice nurses, such as nurse practitioners (NPs) and certified nurse midwives (CNMs), 
are often the only source of primary health care for women, especially in medically underserved areas 
(15). A major focus of NP and CNM practice is health education and promotion of healthy behaviors 
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(16, 17). NPs have led successful cardiovascular disease interven-
tions in smoking cessation (18, 19) and obesity prevention (20) 
which would have crossover benefits for cancer prevention in the 
long term, and their contributions should be utilized to maximize 
prevention efforts for women.
SCREEninG
Early Detection
Nurses have many opportunities to reduce the substantial gaps 
in access to gynecologic and breast cancer screening in the U.S., 
particularly for minority and underserved women (21). NPs 
and CNMs play important roles in providing primary care by 
performing cervical cancer screening, referring women for mam-
mography and colon cancer screening, and then collaborating 
with or transferring care to specialist physicians as necessary (22). 
Despite their education, training, and evidence that their quality 
and patient satisfaction outcomes are equal or superior to that 
of physicians (7, 16, 23), NPs and CNMs are still underutilized 
in extending the reach of cervical and breast cancer screening in 
underserved communities (24, 25).
navigation
Nurses may also work in a navigation role in primary care 
practice, helping patients understand the importance of cancer 
screening and follow-up after abnormal results. As an example, 
nurse navigation demonstrated an increase in women’s follow-up 
colposcopy attendance after abnormal cytology screening (26). 
Utilizing all available nursing professionals in ambulatory settings 
would provide the comprehensive approach needed to improve 
cancer prevention care for women on a broad population level.
DiAGnOSiS AnD TREATMEnT
As integral members of the cancer care team during treatment, 
nurses’ involvement in multidisciplinary cancer care treatment 
models can improve care post-diagnosis through management of 
treatment-related symptom toxicities, and improving adherence 
to treatment.
Symptom and Toxicities Management
Treatment-related symptom toxicities, particularly in novel 
therapies such as targeted agents and immune therapies, are often 
serious but difficult to recognize, and thus likely under reported 
(27). Nurses can play an integral role in the integration of 
patient-reported outcomes related to such therapies, particularly 
during assessment, patient education, and through communica-
tion via patient portals. The Oncology Nursing Society outlines 
competencies for certification of oncology nurses and NPs (28). 
Oncology Certified Nurses (OCN) are trained to provide special-
ized patient care that is validated by certification of knowledge in 
oncology nursing focusing on adults with cancer (29). Oncology 
NPs are specialists in symptom management (30) and discharge 
planning to improve quality of life long term.
In addition, nurses and NPs can offer support and educa-
tion around discussions about sexual health (31) and fertility 
preservation (32). Nurses at the bedside or on research teams are 
essential for effective recruitment of women with gynecologic 
cancer to the clinical trials needed to improve cancer-related care 
(33) and have held leadership positions on gynecologic cancer 
treatment trials (34). Utilization of specially qualified nurses in 
many roles can enhance both the reporting and subsequent treat-
ment of treatment-related symptoms and complications.
Adherence
Cancer centers increasingly utilize nurse navigators to assist 
women through complicated care regimens (35–37), resulting 
in increased adherence to treatment (38) and improved patient 
satisfaction with care (39). In addition, geographic differences 
can play a role in cancer treatment outcome disparities (1, 40). 
Oncology NPs can increase access to care for underserved areas 
through telemedicine and satellite clinics, addressing issues with 
access and facilitating appointment adherence (28). Innovative 
multiprovider visits, including medical and nursing staff, have 
been designed for women who are initiating ovarian cancer 
chemotherapy. Prescott et  al. (41) described a shared medical 
visit model in which a multidisciplinary team, including the 
oncologist, NPs, nurses, and social workers, provided standard-
ized education visits for gynecologic oncology patients planning 
to begin their series of platinum-based chemotherapy sessions. 
Nurses were integral in educating patients on expected side 
effects, coping tools, and the importance of shared decision-
making throughout treatment. Nurse-led support groups can 
be important outlets for patients to support adherence through 
difficult treatment regimens.
Adjuvant hormone therapy, including tamoxifen and aro-
matase inhibitors, is a widely recognized and important compo-
nent of breast cancer treatment for hormone receptor positive 
women. Despite the documented benefits, up to 50% of women 
who are recommended therapy do not initiate therapy or do not 
adhere to the regimen for the recommended 5–10 years, due in 
part to the myriad of side effects of hormonal treatment (42). In 
addition, as many cancer therapies move from intravenous to oral 
medications with complex home regimens, adherence becomes an 
increasingly important area where nurses can improve outcomes. 
Schneider et al. (43) described a small clinical trial (N = 45) of 
tailored nursing education intervention which improved both 
self- and pharmacy-reported adherence to oral chemotherapy 
(93% in intervention vs. 80% in controls at 2 months, no CI given). 
Nurses should play a key role in increasing patient knowledge of 
side effects and remedies, communicating benefits of treatment 
to prevent recurrence, and identifying coping strategies to resolve 
barriers to adherence.
SURViVORSHip
There is a growing need to address the many late and long-term 
effects that plague the growing number of gynecologic cancer 
survivors (44), and nurses at all levels are integral in this care.
navigation posttreatment
While appropriate utilization and implementation of survivor-
ship care plans are still being explored (45, 46), nurse navigators 
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coordinate care as the cancer patient transitions back to primary 
care after active treatment. In addition, primary care, oncology, 
and advanced practice nurses educate the patient throughout 
treatment and into survivorship on managing the transition after 
a cancer diagnosis, including late and long-term effects, as well 
as the on importance of follow-up care after treatment to detect 
recurrence or secondary malignancies (47).
Clinical Care of Survivors
Models of care delivery for survivorship care include primary 
care, gynecologic oncologist-led, and survivorship clinics, 
offering multidisciplinary services. While there are differing 
opinions on the best setting for long-term follow-up and care 
of survivors, and this may differ based on cancer type and 
individual provider or institutions, there is emerging research 
that nurse-led survivorship clinics hold potential for this 
important care (48, 49). A technical report on models of survi-
vorship care indicated that cancer survivors preferred follow-up 
from those with specialized training (50), and pointed to the 
need for more specialized survivorship training for oncology 
nurses and advanced practitioners. In addition, a systematic 
review comparing models of survivorship care for posttreat-
ment follow-up of adult cancer survivors found no significant 
differences in quality of life or disease recurrence outcomes 
for nurse-led follow-up when compared with oncologist-led 
follow-up care. In fact, patient satisfaction was higher for nurse-
led care in one study included in the review (51). Rosenberg and 
colleagues (52) explored the use of survivorship risk-adapted 
follow-up visits facilitated by an oncology nurse and involving 
discussion of survivorship care plans. The authors found that 
of the 1615 breast cancer survivors who participated in the 
intervention, most reported more confidence in understanding 
their diagnosis, treatment summary, and recommendations for 
posttreatment support. Overall, as nurse-led clinics are typi-
cally less costly to an organization, specialized nurses working 
in consultation with physicians could increase availability of 
oncology survivorship services.
EnD-OF-LiFE CARE
When a patient’s prognosis changes and goals of curative treat-
ment transition into advanced care planning, nurses can uniquely 
contribute in many areas. Advanced practice nurses in both 
oncology and primary care settings should be trained to effec-
tively communicate conversations about worsening prognosis 
(53); however, application of this role is unclear in the literature; 
this represents a missed opportunity for improving an essential 
aspect of cancer care. Oncology nurses in both inpatient and 
outpatient settings establish strong relationships with patients 
through many hours of patient contact and can play a substantial 
role in helping patients and families consider their own goals 
and values as they relate to end-of-life care. Research indicates, 
however, that nurses experience ethical dilemmas surrounding 
these conversations, as their role is less defined and they are often 
hesitant to have these conversations with patients and families 
(54, 55). Inpatient nurses, who could be trained in end-of-life 
care, are able to function as “champions,” for example, and act 
as a resource for their team (56). While physician–nurse teams 
are optimal for discussions surrounding end-of-life care, more 
education and training for nurses are important in order to 
optimize communication with advanced cancer patients as their 
prognosis worsens.
COnCLUSiOn
Women diagnosed with gynecologic cancers face difficult and 
complex treatment regimens with long-term health implica-
tions. Innovations and improvements in cancer care delivery in 
women’s health must rely on all members of the health-care team. 
We argue that because the nursing workforce is vastly larger than 
that of gynecologic oncologists, and boasts breadth and depth 
of roles, training, and capabilities, it is essential to better utilize 
and integrate nurses within the multidisciplinary team to ensure 
comprehensive, woman-centered care before, during, and after 
cancer. It is time that women had equitable access to higher qual-
ity cancer care, and nursing is up to the challenge.
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